Upper Respiratory Infection

Upper respiratory infection, commonly abbreviated as URI, refers to infectious diseases affecting the upper portions of the respiratory tract in farm animals, including the nasal passages, sinuses, pharynx, larynx, and trachea. These infections are caused by various viral and bacterial pathogens that target the epithelial lining of the upper airways, causing inflammation, excessive mucus production, and disruption of normal respiratory defense mechanisms. Upper respiratory infections represent one of the most common disease categories affecting livestock worldwide, causing significant economic losses and welfare concerns across all major farm animal species. The upper respiratory tract serves as the primary interface between the external environment and the delicate lower respiratory structures, making it particularly vulnerable to infectious agent invasion.

Upper respiratory infections affect virtually all domesticated farm animal species with varying clinical presentations and causative agents. In cattle, URI commonly involves pathogens including infectious bovine rhinotracheitis virus, bovine respiratory syncytial virus, parainfluenza-3 virus, and bacterial agents such as Mannheimia haemolytica and Pasteurella multocida. Sheep and goats experience upper respiratory infections caused by similar bacterial agents along with species-specific viral pathogens. Pigs are affected by swine influenza virus, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae among others. Poultry face a distinct set of respiratory pathogens including infectious bronchitis virus, Newcastle disease virus, Mycoplasma gallisepticum, and infectious laryngotracheitis virus.

The economic and welfare impact of upper respiratory infections in farm animals is substantial and multifaceted. Production losses include reduced growth rates, decreased feed efficiency, diminished milk production, and reduced egg laying performance. Morbidity rates in outbreaks can approach one hundred percent in susceptible populations, though mortality varies widely depending on the pathogens involved and management response. Treatment costs include veterinary services, antimicrobial medications, and labor for animal care and monitoring. Long-term consequences may include chronic respiratory damage that permanently impairs productivity. From a welfare perspective, affected animals experience discomfort from nasal congestion, difficulty breathing, fever, and general malaise that significantly compromise quality of life during illness.

Upper respiratory infections are generally treatable, particularly when detected early and managed with appropriate veterinary guidance. Viral infections typically require supportive care while the immune system clears the pathogen, with treatment focused on preventing secondary bacterial complications. Bacterial infections respond to appropriate antimicrobial therapy, though selection must consider pathogen susceptibility, withdrawal times for food-producing animals, and regulatory requirements. Prevention through vaccination, biosecurity, and optimal management represents the most effective approach for reducing URI impact on farm animal populations. Early detection through vigilant monitoring enables prompt intervention before severe disease develops or widespread transmission occurs.

The primary causes of upper respiratory infections in farm animals are infectious agents including viruses, bacteria, and occasionally mycoplasma and other organisms. Viral pathogens often initiate infection by damaging the respiratory epithelium and impairing local immune defenses, setting the stage for secondary bacterial invasion. Key viral agents in cattle include infectious bovine rhinotracheitis virus, which causes severe upper respiratory inflammation, and bovine respiratory syncytial virus, which can affect both upper and lower airways. Parainfluenza-3 virus and bovine coronavirus also contribute to respiratory disease complexes. Bacterial pathogens including Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis commonly cause or complicate upper respiratory infections.

Genetic and breed predisposition to upper respiratory infections relates primarily to immune function capacity rather than direct susceptibility factors. Animals from breeding lines with robust immune responses may experience less severe disease when infected. Bos indicus cattle breeds show some resistance to certain respiratory pathogens compared to Bos taurus breeds. However, management factors typically overwhelm any breed-related resistance differences. Young animals face increased susceptibility due to immature immune systems, particularly during the vulnerable period between maternal antibody decline and development of active immunity. Individual animals may show variation in susceptibility based on their specific immune response characteristics.

Environmental and management factors play critical roles in upper respiratory infection occurrence and severity. Poor ventilation in enclosed housing allows pathogen accumulation and transmission through respiratory droplets and aerosols. High stocking densities increase contact rates and stress levels, both facilitating disease spread. Ammonia and dust irritate respiratory mucosa, impairing defense mechanisms. Temperature extremes stress animals and may directly affect pathogen viability and transmission. Commingling of animals from different sources brings together diverse pathogen strains and immunologically naive individuals. Transportation stress significantly increases URI susceptibility, giving rise to the well-recognized shipping fever complex in cattle.

Risk factors for upper respiratory infection development include recent transportation, weaning, commingling, weather changes, and concurrent stressors. Newly arrived animals face highest risk during the first two to three weeks after transport or introduction to new environments. Weaning stress compounds with pathogen exposure in high-risk periods. Seasonal patterns exist for many respiratory pathogens, with increased incidence during fall and winter in temperate climates. Poor nutrition impairs immune function and increases susceptibility. Concurrent diseases, including parasitism and other infections, compromise the animal's ability to mount effective respiratory defenses.

The pathophysiology of upper respiratory infection begins with pathogen entry through inhalation of contaminated droplets or aerosols, or through direct contact with infected animals or contaminated fomites. Viruses attach to and invade respiratory epithelial cells, replicating within them and causing cellular damage and death. The resulting epithelial disruption impairs mucociliary clearance, removes physical barriers to bacterial invasion, and triggers inflammatory responses. Bacteria colonize damaged tissue, producing toxins and eliciting further inflammation. The host immune response, while necessary for pathogen clearance, contributes to clinical signs through fever, inflammation, and excessive mucus production. Uncomplicated upper respiratory infections typically resolve as the immune response controls the pathogen, but complications including lower respiratory tract extension can occur.

Early warning signs of upper respiratory infection in farm animals include subtle behavioral and physical changes that precede obvious clinical disease. Decreased appetite is often the first sign noticed, with animals showing reduced interest in feed or slower eating pace. Mild lethargy and reduced interaction with herd or flock mates may be apparent to observant handlers. Some animals show increased time lying down or decreased movement within their environment. A slight increase in respiratory rate or occasional cough may occur. Early nasal discharge is typically clear and serous before progressing to thicker consistency. These early signs provide opportunities for intervention before severe disease develops.

Common symptoms by species reflect differing anatomies and typical pathogens affecting each. In cattle, upper respiratory infection commonly presents with serous to mucopurulent nasal discharge, increased lacrimation, mild to moderate fever, coughing, and depression. Sheep and goats show similar signs with nasal discharge, sneezing, mild dyspnea, and reduced appetite. Pigs with URI display sneezing, coughing, conjunctivitis, and nasal discharge that may be accompanied by fever. Poultry present with distinct signs including facial swelling, oculonasal discharge, sneezing, head shaking, and respiratory sounds ranging from rales to distinct snicking sounds. Laying hens may show decreased egg production as an early indicator.

Behavioral changes associated with upper respiratory infection reflect the systemic effects of infection and localized discomfort. Affected animals show decreased activity levels and reluctance to move about their environment. Feed and water intake typically decline, leading to dehydration if not addressed. Social interactions decrease, with sick animals often separating from the group. Cattle and small ruminants may display ear drooping as an indicator of malaise. Animals may seek warmer or cooler locations depending on fever status. Reduced grooming behavior may be noticeable. Vocalizations may change in character due to laryngeal involvement.

Physical signs of upper respiratory infection become more pronounced as disease progresses. Nasal discharge increases in volume and changes from clear to white, yellow, or green purulent material. Discharge may accumulate around the nostrils and on the face. Increased respiratory rate and effort become apparent, with some animals showing nostril flare during breathing. Coughing becomes more frequent and may be productive. Fever, typically ranging from moderate to high depending on the pathogen involved, can be detected on rectal temperature measurement. Conjunctivitis with ocular discharge commonly accompanies nasal signs. Lymph nodes in the head and neck region may be enlarged and palpable.

Symptom progression in upper respiratory infections follows a pattern determined by the causative agent and development of complications. Initial mild signs intensify over two to five days as infection establishes. Peak disease severity typically occurs within one week of infection onset. Uncomplicated viral infections may begin resolving after five to ten days as immune responses control replication. Secondary bacterial infections prolong and intensify clinical signs. Progression to lower respiratory involvement, indicated by increased respiratory effort, abnormal lung sounds, and worsening fever, represents a serious escalation. Without appropriate intervention, severely affected animals may become debilitated with marked weight loss.

Emergency symptoms requiring immediate veterinary intervention include severe respiratory distress, high fever unresponsive to initial treatment, complete anorexia, and signs of systemic illness. Open-mouth breathing indicates serious airway compromise requiring urgent attention. Marked depression or recumbency suggests severe systemic disease. Bloody nasal discharge may indicate severe mucosal damage or specific pathogens. Neurological signs in some infections indicate serious complications. Rapid deterioration despite treatment warrants immediate reassessment. Young animals and those with concurrent disease may decompensate quickly and require intensive intervention.

Clinical examination forms the foundation of upper respiratory infection diagnosis in farm animals. The veterinarian observes the animal's overall demeanor, respiratory pattern, and presence of discharge before approaching for hands-on evaluation. Vital parameter assessment includes temperature, pulse, and respiratory rate, with fever being a common finding. Auscultation of the trachea and lung fields identifies abnormal respiratory sounds including increased harshness, rales, or wheezes. Examination of the nasal passages, eyes, and oral cavity reveals inflammation and discharge characteristics. Palpation of regional lymph nodes assesses for enlargement. Complete physical examination identifies concurrent conditions affecting management decisions.

Diagnostic tests help identify specific pathogens and guide treatment decisions. Nasal swabs can be submitted for viral isolation, polymerase chain reaction testing, or bacterial culture and sensitivity. Deep nasopharyngeal swabs provide better samples for many pathogens. Serology can demonstrate exposure to specific viruses through antibody detection, though paired acute and convalescent samples are needed for definitive diagnosis. Transtracheal wash or bronchoalveolar lavage may be performed in valuable individuals to obtain samples from the lower respiratory tract. In poultry, choanal and tracheal swabs are commonly used. Blood work including complete blood count may reveal changes consistent with infection.

Differential diagnosis for upper respiratory infection includes various conditions causing similar clinical signs. Allergic rhinitis produces nasal discharge without fever or systemic illness. Foreign body aspiration may cause unilateral nasal discharge. Nasal tumors produce chronic progressive signs. Dental disease in small ruminants can cause nasal discharge. Non-infectious causes of respiratory distress including heat stress, toxin exposure, and metabolic disease must be considered. Notifiable diseases with respiratory presentations, such as foot-and-mouth disease, must be ruled out when clinical signs are compatible. The veterinarian considers signalment, history, clinical findings, and diagnostic results to differentiate among possible causes.

Herd-level diagnostics become essential when respiratory disease affects multiple animals, suggesting contagious pathogen involvement. Evaluation of morbidity and mortality patterns provides epidemiological clues to causative agents. Serological surveys can assess population exposure to specific pathogens. Postmortem examination of severely affected or deceased animals provides valuable diagnostic material for pathology, culture, and molecular testing. Environmental assessment evaluates housing conditions, ventilation adequacy, and stocking density. Review of recent management events including animal introductions, transportation, and procedure timing may reveal triggering factors. These herd-level investigations guide population-wide intervention strategies.

Emergency and immediate treatment of severe upper respiratory infection focuses on stabilizing critical patients and preventing deterioration. Animals with high fever receive antipyretic medications, typically non-steroidal anti-inflammatory drugs that also provide analgesic and anti-inflammatory effects. Severely depressed or dehydrated animals may require fluid therapy to restore hydration and support circulation. Animals with marked respiratory distress may benefit from anti-inflammatory medications to reduce airway swelling. Isolation of severely affected individuals prevents transmission while enabling closer monitoring and care. Provision of easily accessible feed and water supports the animal through acute illness.

Medical management of upper respiratory infection centers on antimicrobial therapy for bacterial components and supportive care for viral infections. Antimicrobial selection should be based on likely pathogens, local resistance patterns, and ideally culture and sensitivity results. Commonly used agents include oxytetracycline, florfenicol, tilmicosin, tulathromycin, and ceftiofur, with selection guided by efficacy, withdrawal times, and practical considerations. Treatment typically continues for three to seven days depending on the specific protocol and agent used. Concurrent anti-inflammatory therapy reduces fever and inflammation. Mucolytic agents may help loosen thick secretions. Treatment of concurrent conditions addresses factors complicating recovery.

Surgical intervention is rarely indicated for uncomplicated upper respiratory infection but may be considered for specific complications. Drainage of abscesses developing secondary to infection may be required. Tracheostomy might be necessary in rare cases of severe upper airway obstruction. Sinus trephination may be needed if sinusitis develops as a complication. These procedures are typically reserved for valuable individual animals or severe complications not responding to medical management.

Supportive care complements antimicrobial therapy and addresses the animal's overall comfort and recovery needs. Providing a clean, well-ventilated environment away from drafts supports respiratory function. Soft, palatable feeds encourage intake in animals with reduced appetite. Ensuring easy access to fresh water prevents dehydration. Protection from temperature extremes reduces additional physiological stress. Minimizing handling and disturbance allows the animal to rest and direct energy toward recovery. Monitoring appetite, hydration, and clinical signs guides ongoing care adjustments.

Herd treatment protocols are activated when multiple animals are affected, indicating a contagious disease outbreak. Metaphylactic treatment of clinically normal but exposed animals may be considered to prevent disease development, with antimicrobial selection and use guided by veterinary oversight and stewardship principles. Affected animals should be separated from the main group when practical to reduce transmission. Environmental modifications including improved ventilation and reduced stocking density limit pathogen spread. Vaccination programs may be implemented or accelerated during outbreaks, though efficacy during active disease spread varies.

Treatment decisions must incorporate economic considerations alongside medical factors. The cost of treatment including veterinary services, medications, and labor must be weighed against the animal's value and expected production. Withdrawal times for meat and milk must be carefully observed in food-producing animals, requiring documentation of drug administration and calculation of slaughter or milk discard dates. Animals failing to respond to initial treatment require reassessment of diagnosis and therapy. Those with poor prognosis despite treatment may warrant culling decisions. Producers should work with their veterinarians to establish treatment protocols balancing animal welfare, economic realities, and food safety.

Recovery timeline for upper respiratory infection varies based on the causative pathogen, disease severity, and presence of complications. Uncomplicated viral infections typically show clinical improvement within five to seven days as the immune response controls viral replication. Bacterial infections treated with appropriate antimicrobials generally improve within three to five days of treatment initiation. Complete return to normal health may take two to three weeks following resolution of clinical signs. Complicated cases involving lower respiratory extension or other complications require longer recovery periods, potentially several weeks to months. Some animals may retain residual respiratory damage affecting long-term performance.

Post-treatment care and monitoring support complete recovery and identify potential complications. Animals should be observed daily for continued improvement in appetite, activity, and respiratory status. Recurrence of fever or respiratory signs after initial improvement may indicate treatment failure, complications, or reinfection. Completion of prescribed antimicrobial courses is important even when clinical improvement occurs to prevent relapse from incompletely treated infection. Gradual return to normal management and production expectations prevents overloading recovering animals. Follow-up veterinary examination may be warranted for valuable individuals or those with incomplete resolution.

Prognosis factors for upper respiratory infection recovery include the specific pathogen involved, disease severity at treatment initiation, and presence of complications. Mild to moderate cases treated promptly carry good prognosis for complete recovery. Severe cases or those with delayed treatment have guarded prognosis, with increased risk of complications and chronic effects. Young animals and those with concurrent disease face higher morbidity and mortality. Development of lower respiratory disease significantly worsens prognosis. Herd-level factors including nutrition status, ongoing pathogen exposure, and management quality influence population-level outcomes.

Return to production considerations guide management of recovered animals. Animals must complete any required drug withdrawal periods before milk can be sold or animals can be slaughtered for food. Production parameters including weight gain, milk yield, and reproductive performance may require several weeks to return to normal following recovery. Animals should demonstrate consistent feed intake and normal clinical status before resuming full production demands. Breeding animals should show complete recovery before being used for reproduction. Chronic respiratory damage may permanently reduce performance capacity in some recovered animals.

Vaccination protocols form a cornerstone of upper respiratory infection prevention in farm animals. Multivalent respiratory vaccines are available for cattle targeting major viral pathogens including IBR, BRSV, PI3, and BVD, along with bacterial agents such as Mannheimia haemolytica and Pasteurella multocida. Modified live and killed vaccine options exist, with selection based on specific farm circumstances and veterinary recommendations. Vaccination timing should provide protection before high-risk periods including weaning, transport, and seasonal disease peaks. Booster schedules maintain immunity over time. Poultry vaccination programs address infectious bronchitis, Newcastle disease, and other respiratory pathogens. Working with a veterinarian ensures appropriate vaccine selection and scheduling.

Biosecurity measures reduce the introduction and spread of respiratory pathogens within farm animal populations. Quarantine of new animals for two to three weeks before introduction allows observation for disease and reduces pathogen introduction risk. Limiting visitor access to animal areas and requiring biosecurity measures for essential visitors prevents pathogen entry. Avoiding equipment sharing between farms eliminates fomite transmission. All-in-all-out management in compatible production systems breaks disease cycles. Prompt isolation of animals showing respiratory signs limits transmission to susceptible individuals. Cleaning and disinfection of facilities between animal groups reduces environmental pathogen loads.

Nutritional prevention strategies support robust immune function capable of resisting or limiting respiratory infections. Adequate protein and energy intake maintains immune cell populations and function. Trace mineral supplementation, particularly selenium, copper, and zinc, supports multiple aspects of immune response. Vitamin supplementation, especially vitamins A and E, promotes respiratory epithelial health and antioxidant defenses. Colostrum management in neonates provides passive immunity critical for the first weeks of life. Avoiding nutritional stress during high-risk periods maintains immunocompetence when it is most needed.

Management practices significantly influence upper respiratory infection risk and can be optimized for prevention. Proper ventilation in enclosed housing removes pathogens and respiratory irritants while maintaining comfortable conditions. Appropriate stocking densities reduce stress and limit direct contact transmission. Dust and ammonia control through good bedding management protects respiratory mucosa. Minimizing stress from handling, transport, and management procedures during high-risk periods reduces susceptibility. Pre-conditioning programs for cattle before transport include vaccination and acclimation to reduce shipping fever risk. Weather protection prevents temperature stress.

Quarantine and testing protocols provide systematic approaches to disease prevention at population levels. New animal introductions should include health screening, vaccination if needed, and observation periods before joining established groups. Testing for specific pathogens may be warranted for new introductions or when investigating disease outbreaks. Establishing and maintaining closed herds when practical minimizes pathogen introduction risk. Regular monitoring of respiratory health indicators enables early detection of disease trends. Postmortem examination of animals dying with respiratory signs provides diagnostic information guiding prevention efforts. Veterinary consultation helps develop comprehensive prevention programs appropriate to each operation's specific needs and risks.

Daily management and monitoring of farm animals should include routine assessment for respiratory health as part of standard observation protocols. Personnel should be trained to recognize early signs of respiratory disease including nasal discharge, coughing, increased respiratory rate, and behavioral changes. Observation during feeding provides opportunity to identify animals with reduced appetite or abnormal eating behavior. Listening for coughing or abnormal respiratory sounds during quiet periods helps detect early cases. Individual animals appearing abnormal should be examined more closely and separated for monitoring if respiratory disease is suspected. Prompt identification and response to early cases improves individual outcomes and reduces transmission risk.

Housing and environmental management directly impact respiratory health and disease susceptibility. Ventilation systems must effectively remove moisture, ammonia, dust, and airborne pathogens while maintaining appropriate temperature and avoiding cold drafts on animals. Ammonia levels should be maintained below recommended thresholds, typically ten parts per million or less. Dust control through appropriate litter or bedding management, feed form selection, and facility maintenance protects respiratory mucosa. Temperature management prevents both cold stress and heat stress that can compromise respiratory function. Humidity control maintains air quality and limits pathogen survival in the environment.

Herd health programs integrate respiratory disease prevention and management into comprehensive animal health strategies. Regular veterinary visits provide expert assessment of respiratory health status and program effectiveness. Vaccination programs are scheduled and implemented systematically. Parasite control programs address respiratory parasites where relevant. Biosecurity protocols are established and enforced. Treatment protocols for respiratory disease cases are developed in advance for consistent responses. Monitoring and review of respiratory health metrics guide program adjustments. Staff training ensures consistent implementation of health program components.

Record keeping and monitoring systems track respiratory disease occurrence and outcomes to inform management decisions. Individual animal health records document respiratory disease cases, treatments, and responses. Morbidity and mortality records reveal disease patterns and trends over time. Treatment records ensure proper withdrawal time documentation and compliance. Environmental monitoring data track relevant parameters including temperature, humidity, and air quality. Regular review of records with the veterinary advisor identifies areas for improvement and assesses program effectiveness. Records also support investigation when disease outbreaks occur.

Economic considerations permeate respiratory health management decisions at all levels. Prevention investments including vaccination, ventilation improvements, and biosecurity measures should be evaluated against expected disease reduction benefits. Treatment costs include veterinary services, medications, labor, and production losses during illness. Chronic effects on productivity must be considered in economic analyses. Cost-benefit analysis of different prevention and treatment strategies guides resource allocation. Market conditions affect economic thresholds for treatment decisions. Regular economic assessment ensures respiratory health programs remain appropriately scaled to actual risks and returns.

High-risk breeds and species for upper respiratory infection include those facing increased pathogen exposure, physiological stress, or management factors elevating susceptibility. Feedlot cattle face elevated respiratory disease risk due to transport stress, commingling, and environmental challenges associated with the feeding period. Newly weaned animals of all species experience heightened susceptibility during the transition period. Commercial poultry raised in intensive production systems have high respiratory disease pressure. Dairy calves, particularly those in group housing, commonly experience respiratory infections. High-producing dairy cattle may face increased stress affecting immune function. Animals with inherently compromised respiratory anatomy face increased risk if infections occur.

Production type considerations significantly affect upper respiratory infection risk profiles. Intensive confinement systems create different challenges than extensive pasture-based production. High-density housing increases pathogen transmission potential. Continuous flow systems maintain disease cycling compared to all-in-all-out management. Production stages with heightened stress, including weaning, transport, and peak lactation, represent vulnerable periods. Breeding animals selected primarily for production traits may have reduced disease resistance compared to heritage breeds. Understanding production system-specific risks enables targeted prevention strategies.

Genetic selection and testing offer opportunities for improving population-level resistance to respiratory disease over time. Selection for general immune competence and disease resistance can reduce susceptibility without targeting specific pathogens. Animals with consistently poor respiratory health outcomes should be considered for culling rather than breeding. Purchase of breeding stock from sources with excellent respiratory health records reduces introduction of susceptible genetics. Crossbreeding programs may introduce disease resistance from more robust populations. While specific genetic markers for URI resistance are not widely available for livestock, ongoing research may enable more targeted selection in the future.

Commonly co-occurring conditions with upper respiratory infection include other infectious and non-infectious problems sharing risk factors or developing as complications. Pneumonia, lower respiratory tract infection, frequently develops when upper respiratory pathogens extend deeper into the airways or when mucosal damage allows secondary pathogen entry. Sinusitis may accompany or complicate nasal infections. Conjunctivitis commonly occurs alongside nasal disease due to anatomical connections. Otitis media can develop through Eustachian tube spread of infection. Systemic manifestations including arthritis, meningitis, or septicemia may occur with certain pathogens. Concurrent gastrointestinal disease from stress or shared pathogens is common in outbreak situations.

Conditions with similar symptoms requiring differentiation from infectious upper respiratory disease include non-infectious causes of respiratory signs. Allergic respiratory disease produces nasal discharge and respiratory signs without fever. Aspiration of foreign material causes acute respiratory distress. Parasitic respiratory disease, including lungworm, causes coughing and respiratory signs. Toxin exposure may produce respiratory irritation. Heat stress causes increased respiratory rate without infection. Cardiac disease can manifest as respiratory difficulty. Environmental irritants including high ammonia or dust levels cause respiratory signs. Accurate diagnosis enables appropriate treatment selection.

Complications and sequelae of upper respiratory infection can have lasting effects on affected animals. Lower respiratory tract extension resulting in bronchopneumonia significantly increases morbidity and mortality. Chronic rhinitis or sinusitis may persist following acute infection. Tracheal damage may lead to chronic respiratory compromise. Septicemia from respiratory pathogens entering the bloodstream causes systemic disease. Weight loss and production setbacks during illness may have lasting performance impacts. Chronic carriers of some respiratory pathogens may develop, serving as sources for future outbreaks. Permanent lung damage reduces exercise tolerance and productivity in recovered animals.